article · Clinical Therapeutics

Diagnostic and Prognostic Roles of Inflammatory Biomarkers in Patients With Coronary Heart Disease and Heart Failure Treated With Empagliflozin

20252 citationsTanta University Hospital

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Diabetes Treatment and Management
Adipokines, Inflammation, and Metabolic Diseases
GDF15 and Related Biomarkers

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.clinthera.2025.04.019

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.